Skip to content

Author

E. Maillart

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.

BACKGROUND Air pollution has been proposed as a short-term trigger of multiple sclerosis (MS) relapses, but delayed effects remain poorly studied in the era of modern disease-modifying therapies (DMTs). We investigated whether weekly air pollution exposure was associated with delayed MS relapse risk up to 15 weeks. M...

E. Januel, C. Papeix, A. Baudic et al. · 0 citations
Open access Sep 2026

Serum GFAP and Age Accurately Distinguish AQP4‐IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack

ABSTRACT Background Serum neurofilament‐light chain (sNfL) and glial fibrillary acidic protein (sGFAP) are associated with multiple sclerosis (MS) activity. This study aimed to identify patient‐ and disease‐level determinants of sNfL and sGFAP and to evaluate their ability to support differential diagnosis in neuromyel...

M. Rival, F. Rollot, Sabine Laurent-Chabalier et al. · 0 citations
Aug 2026

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

BACKGROUND Ofatumumab and ocrelizumab are widely used high-efficacy anti-CD20 therapies for relapsing-remitting multiple sclerosis (RRMS), but direct comparative evidence remains limited. We aimed to compare their effectiveness in routine clinical practice. METHODS We conducted an observational cohort study emulating...

Chao Zhu, S. Vukusic, T. Kalincik et al. · 0 citations
Open access Jul 2026

French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.

Management of attacks as well as the prevention of relapses is crucial to limit functional sequelae and disability, and the rapid and individualized management of attacks is crucial to limit functional sequelae and disability.

L. Giorgi, R. Marignier, J. Pique et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.